Trials / Completed
CompletedNCT00940134
Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.
INGEAR-1: Effects of INtravenous Infusions of PYY3-36 and GLP-1, as Monoinfusion and in Combination, on ad Libitum Energy Intake, Appetite Sensation, and Energy Expenditure in Healthy Obese Subjects.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effects of intravenous infusion of two gastrointestinal hormones, PYY3-36 and GLP-1, alone and in combination, on appetite in healthy obese men. The investigators hypothesize that an intravenous infusion of each hormone alone will decrease food intake at a buffet meal and decrease appetite, and that in combination, there will be a greater decrease in food intake and appetite compared to each hormone alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PYY 3-36 | 0.8 pmol/kg/min x 3 hours |
| BIOLOGICAL | GLP-1 | 1.0 pmol/kg/min x 3 hours |
| BIOLOGICAL | saline infusion | saline infusion x 3 hours |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2009-07-15
- Last updated
- 2012-06-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00940134. Inclusion in this directory is not an endorsement.